MolecularMatch

MolecularMatch is a precision oncology clinical informatics and SaaS company that provides software to match cancer patients to evidence-based therapies and clinical trials using tumor molecular profiling data. Founded out of MD Anderson Cancer Center in Houston, the company built proprietary treatment algorithms, molecular knowledge aggregation tools, and search capabilities for oncology decision support. Its products have included MMPower, a molecular search and clinical decision support platform, and MMPortal for physician-facing molecular guidance. MolecularMatch has served genetic laboratories, health information systems, biopharma companies, hospitals, and cancer centers. Available sources indicate the business was commercially active for years and completed an acquisition transaction in June 2024, though the acquirer and transaction terms were not clearly identified in accessible public sources.